The research team of AGILeBiotics will attend the 11th conference on Novel Antimicrobial and AMR Diagnostics in Berlin (Germany) on 2 March, 2018. A pitch presentation will be given by the CEO Dr. Andreas A Bastian.
Menu
News
About
AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections
